More forecasts: Atlanta 30 day forecast
Assertio Therapeutics Settles for $3.6 Million Over Alleged False Claims Act Violations Linked to Fentanyl Marketing
May 10, 2025
Assertio Therapeutics settled for $3.6 million over False Claims Act violations regarding the marketing of the fentanyl product Lazanda, which included targeting high-prescribing pain specialists.












